Abstract: The present invention relates to the use of calcitonin gene-related peptide (CGRP) in the prevention and alleviation of asthmatic symptoms. In contrast to other therapeutic agents now in use, CGRP combines both bronchoprotector and anti-inflammatory properties. Furthermore, it prevents both early and late phase bronchial responses associated with an asthma attack and its effective dose is small enough that undesirable haemodynamic side effects are not present.
Abstract: A process and an apparatus for manufacturing electrocatalytic electrodes. The process comprises the steps of immersing a substrate in a plating bath containing metal ions and electrocatalytic material in particles form, such as Ni, NiAl, and CoAl, among others. Electric current is established in the bath inducing a deposition of metal on the substrate by reduction of metal ions and, simultaneously, the cell containing the plating bath is inverted periodically to cause a recurrent migration of the particles of electrocatalytic material, under the effect of gravity, toward the substrate, in order to build-up a layer of electrocatalytic material on the substrate, the particles of the electrocatalytic material being fixed on the substrate by the reduction of metal ions.
Type:
Grant
Filed:
November 21, 1988
Date of Patent:
April 10, 1990
Assignee:
Sherbrooke University
Inventors:
Hugues Menard, Louis Brossard, Yves Choquette